EcoR1 Capital is a San Francisco-based fundamental biotechnology-focused investment advisory firm, active in private equity and hedge fund asset classes, established in 2012. The firm evaluates and selects exceptional biotechnology companies, aiming to advance medical research through investments in compelling biotech companies developing promising new solutions for untreated diseases.
Oleg Nodelman
Oleg Nodelman is the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013 that invests across all stages of research and development. With over 20 years of biotech investing experience, he previously served as a portfolio manager at BVF Partners. Mr. Nodelman is a Board Member of AnaptysBio (NASDAQ: ANAB) and Galapagos (Euronext & NASDAQ: GLPG), both clinical-stage biotechnology companies. He holds a BS in Foreign Service with a focus on Science and Technology from Georgetown University.
Active 13D Positions
Stock | Company name | Sector | % of Portfolio | Link |
GLPG | Galapagos NV - ADR | HEALTH CARE | 0.2% |
Comments